Melola Discovery

← Melola Discovery

Akses terbuka Jurnal

Traditional Medicine Innovation Policy: Between the Protection of Traditional Knowledge, Genetic Resources, and Intellectual Property

Legality: Jurnal Ilmiah Hukum · Vol. 34 No. 2 (2026) · hlm. 369–401

DOI
10.22219/ljih.v34i2.43917
ISSN
2549-4600, 0854-6509
Terbit
2026-06-08
Penerbit
Faculty of Law, University of Muhammadiyah Malang
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-sa/4.0

Abstrak

This study analyses how innovation in traditional medicine can be strengthened through the convergence of policies on traditional knowledge protection, genetic resources governance, and intellectual property rights to support national independence in drug availability. Using a qualitative normative design, this research examines statutory regulations, international instruments, and institutional practices relevant to traditional medicine, biogenetic conservation, and intellectual property management. The methodological approach includes doctrinal legal analysis, conceptual analysis, and policy evaluation to map regulatory overlaps, gaps, and strategic opportunities for integration. The study finds that Indonesia possesses vast biodiversity and rich traditional medicinal knowledge that remain underutilised in pharmaceutical innovation. Regulatory frameworks governing traditional knowledge, genetic resource access, and intellectual property work in parallel but lack harmony, resulting in problems related to standardisation, benefit-sharing, research authorisation, and commercialisation. Findings also indicate that strengthening scientific validation, through standardised extraction, preclinical and clinical testing, and quality assurance, significantly increases the potential of traditional medicines to advance into standardised herbal medicines and phytopharmaceuticals. The study concludes that policy convergence is essential to ensure equitable protection of traditional knowledge, sustainable use of genetic resources, and effective commercialisation of research outputs. An integrated framework is required to support national drug independence, enhance bioeconomic value creation, and promote fair benefit distribution for indigenous and local communities.

Kata kunci

Jaringan kolaborasi para penulis

23 penulis · 49 tautan kepenulisan bersama · 28 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Diponegoro University
  • National University of Malaysia
  • Universitas Tidar
  • University of Wollongong
  • The University of Melbourne
  • International University of Batam
  • Islamic University of Indonesia
  • Organisasi lain
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
RAHAYU RAHAYUDiponegoro University3
Arnanda YusliwidakaUniversitas Tidar3
Priska Maulidina Ayu AnantaDiponegoro University1
Bunga Jasmine Puji HapsariAfiliasi tidak diketahui1
Faza RusdaAfiliasi tidak diketahui1
Muhamad Nafi Uz ZamanDiponegoro University1
Zinatul Ashiqin ZainolNational University of Malaysia1
Mohd Zamre Mohd ZahirNational University of Malaysia1
Zaki MubarokUniversity of Wollongong1
Ajar BuditamaThe University of Melbourne1
Saidatul Nadia Abd AzizNational University of Malaysia1
Peni SusetyoriniDiponegoro University1
Joko SetiyonoDiponegoro University1
Hari Sutra DisemadiInternational University of Batam1
Khansadhia Afifah WardanaDiponegoro University1
Rahayu RahayuDiponegoro University1
Vania Lutfi Safira ErlanggaIslamic University of Indonesia1
Sartika Nanda LestariUniversity of Aberdeen1
Dela PuspitaDiponegoro University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://ejournal.umm.ac.id/index.php/legality/oai, pertama di-harvest 7 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Traditional Medicine Innovation Policy: Between the Protection of Traditional Knowledge, Genetic Resources, and Intellectual Property</dc:title>
	<dc:creator>Roisah, Kholis</dc:creator>
	<dc:creator>Asy'arie, Moh. Asadullah Hasan Al</dc:creator>
	<dc:creator>Rahayu, Rahayu</dc:creator>
	<dc:creator>Zulfah, Shofiy</dc:creator>
	<dc:subject xml:lang="en-US">Traditional Knowledge</dc:subject>
	<dc:subject xml:lang="en-US">Genetic Resources</dc:subject>
	<dc:subject xml:lang="en-US">Traditional Medicine Innovation</dc:subject>
	<dc:description xml:lang="en-US">This study analyses how innovation in traditional medicine can be strengthened through the convergence of policies on traditional knowledge protection, genetic resources governance, and intellectual property rights to support national independence in drug availability. Using a qualitative normative design, this research examines statutory regulations, international instruments, and institutional practices relevant to traditional medicine, biogenetic conservation, and intellectual property management. The methodological approach includes doctrinal legal analysis, conceptual analysis, and policy evaluation to map regulatory overlaps, gaps, and strategic opportunities for integration. The study finds that Indonesia possesses vast biodiversity and rich traditional medicinal knowledge that remain underutilised in pharmaceutical innovation. Regulatory frameworks governing traditional knowledge, genetic resource access, and intellectual property work in parallel but lack harmony, resulting in problems related to standardisation, benefit-sharing, research authorisation, and commercialisation. Findings also indicate that strengthening scientific validation, through standardised extraction, preclinical and clinical testing, and quality assurance, significantly increases the potential of traditional medicines to advance into standardised herbal medicines and phytopharmaceuticals. The study concludes that policy convergence is essential to ensure equitable protection of traditional knowledge, sustainable use of genetic resources, and effective commercialisation of research outputs. An integrated framework is required to support national drug independence, enhance bioeconomic value creation, and promote fair benefit distribution for indigenous and local communities.</dc:description>
	<dc:publisher xml:lang="en-US">Faculty of Law, University of Muhammadiyah Malang</dc:publisher>
	<dc:date>2026-06-08</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://ejournal.umm.ac.id/index.php/legality/article/view/43917</dc:identifier>
	<dc:identifier>10.22219/ljih.v34i2.43917</dc:identifier>
	<dc:source xml:lang="en-US">Legality : Jurnal Ilmiah Hukum; Vol. 34 No. 2 (2026): September; 369-401</dc:source>
	<dc:source>2549-4600</dc:source>
	<dc:source>0854-6509</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://ejournal.umm.ac.id/index.php/legality/article/view/43917/18724</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2026 Kholis Roisah, Moh. Asadullah Hasan Al Asy'arie, Rahayu Rahayu, Shofiy Zulfah</dc:rights>
	<dc:rights xml:lang="en-US">https://creativecommons.org/licenses/by-sa/4.0</dc:rights>
</oai_dc:dc>